NodThera, the leading clinical-stage NLRP3 company developing a portfolio of best-in-class brain-penetrant and immune-targeted oral inhibitors to address cardiometabolic and neuroinflammatory diseases ...
CAMBRIDGE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that managem ...
After the 24-day extravaganza that was the World Darts Championship, the sport's best and most-loved players are going head to head over 17 weeks of Premier League action. World No. 2 Luke Humphries ...